Account wins from the 06/06/06 News Brief
Seidler Bernstein is developing an international marketing and communications program for Dako’s Serum HER-2/neu, a biomarker assay for metastatic breast ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.